Global Recurrent Glioblastoma Multiforme Treatment Market Research Report 2019

Table of Contents

Executive Summary

1 Recurrent Glioblastoma Multiforme Treatment Market Overview

• 1.1 Product Overview and Scope of Recurrent Glioblastoma Multiforme Treatment
• 1.2 Recurrent Glioblastoma Multiforme Treatment Segment by Type
  • 1.2.1 Global Recurrent Glioblastoma Multiforme Treatment Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 AU-105
  • 1.2.3 Axitinib
  • 1.2.4 AXL-1717
  • 1.2.5 AZD-7451
  • 1.2.6 Others
• 1.3 Recurrent Glioblastoma Multiforme Treatment Segment by Application
  • 1.3.1 Recurrent Glioblastoma Multiforme Treatment Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.3 Global Recurrent Glioblastoma Multiforme Treatment Market by Region
  • 1.3.1 Global Recurrent Glioblastoma Multiforme Treatment Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Recurrent Glioblastoma Multiforme Treatment Market Size
  • 1.4.1 Global Recurrent Glioblastoma Multiforme Treatment Revenue (2014-2025)
  • 1.4.2 Global Recurrent Glioblastoma Multiforme Treatment Production (2014-2025)

2 Global Recurrent Glioblastoma Multiforme Treatment Market Competition by Manufacturers

• 2.1 Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Recurrent Glioblastoma Multiforme Treatment Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Recurrent Glioblastoma Multiforme Treatment Production Sites, Area Served, Product Types
• 2.5 Recurrent Glioblastoma Multiforme Treatment Market Competitive Situation and Trends
  • 2.5.1 Recurrent Glioblastoma Multiforme Treatment Market Concentration Rate
  • 2.5.2 Recurrent Glioblastoma Multiforme Treatment Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Regions

• 3.1 Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Regions
• 3.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Regions (2014-2019)
• 3.3 Global Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Recurrent Glioblastoma Multiforme Treatment Production
  • 3.4.1 North America Recurrent Glioblastoma Multiforme Treatment Production Growth Rate (2014-2019)
  • 3.4.2 North America Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Recurrent Glioblastoma Multiforme Treatment Production
  • 3.5.1 Europe Recurrent Glioblastoma Multiforme Treatment Production Growth Rate (2014-2019)
  • 3.5.2 Europe Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Recurrent Glioblastoma Multiforme Treatment Production (2014-2019)
  • 3.6.1 China Recurrent Glioblastoma Multiforme Treatment Production Growth Rate (2014-2019)
  • 3.6.2 China Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Recurrent Glioblastoma Multiforme Treatment Production (2014-2019)
  • 3.7.1 Japan Recurrent Glioblastoma Multiforme Treatment Production Growth Rate (2014-2019)
  • 3.7.2 Japan Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Recurrent Glioblastoma Multiforme Treatment Consumption by Regions

• 4.1 Global Recurrent Glioblastoma Multiforme Treatment Consumption by Regions
• 4.2 North America Recurrent Glioblastoma Multiforme Treatment Consumption (2014-2019)
• 4.3 Europe Recurrent Glioblastoma Multiforme Treatment Consumption (2014-2019)
• 4.4 China Recurrent Glioblastoma Multiforme Treatment Consumption (2014-2019)
• 4.5 Japan Recurrent Glioblastoma Multiforme Treatment Consumption (2014-2019)

5 Global Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price Trend by Type

• 5.1 Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Type (2014-2019)
• 5.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Type (2014-2019)
• 5.3 Global Recurrent Glioblastoma Multiforme Treatment Price by Type (2014-2019)
• 5.4 Global Recurrent Glioblastoma Multiforme Treatment Production Growth by Type (2014-2019)

6 Global Recurrent Glioblastoma Multiforme Treatment Market Analysis by Applications

• 6.1 Global Recurrent Glioblastoma Multiforme Treatment Consumption Market Share by Application (2014-2019)
• 6.2 Global Recurrent Glioblastoma Multiforme Treatment Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Recurrent Glioblastoma Multiforme Treatment Business

• 7.1 Boehringer Ingelheim GmbH
  • 7.1.1 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.1.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.1.3 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Boston Biomedical, Inc.
  • 7.2.1 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.2.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.2.3 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Bristol-Myers Squibb Company
  • 7.3.1 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.3.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.3.3 Bristol-Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Cantex Pharmaceuticals, Inc.
  • 7.4.1 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.4.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.4.3 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Cavion LLC
  • 7.5.1 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.5.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.5.3 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Celldex Therapeutics, Inc.
  • 7.6.1 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.6.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.6.3 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Coherus BioSciences, Inc.
  • 7.7.1 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.7.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.7.3 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Cortice Biosciences, Inc.
  • 7.8.1 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.8.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.8.3 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Eisai
  • 7.9.1 Eisai Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.9.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.9.3 Eisai Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Eli Lilly and Company
  • 7.10.1 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Production Sites and Area Served
  • 7.10.2 Recurrent Glioblastoma Multiforme Treatment Product Introduction, Application and Specification
  • 7.10.3 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 EnGeneIC Ltd
• 7.12 ERC Belgium SA
• 7.13 GenSpera, Inc.
• 7.14 Genzyme Corporation
• 7.15 GW Pharmaceuticals Plc
• 7.16 ImmunoCellular Therapeutics, Ltd.

8 Recurrent Glioblastoma Multiforme Treatment Manufacturing Cost Analysis

• 8.1 Recurrent Glioblastoma Multiforme Treatment Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Recurrent Glioblastoma Multiforme Treatment
• 8.4 Recurrent Glioblastoma Multiforme Treatment Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Recurrent Glioblastoma Multiforme Treatment Distributors List
• 9.3 Recurrent Glioblastoma Multiforme Treatment Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast

• 11.1 Global Recurrent Glioblastoma Multiforme Treatment Production, Revenue Forecast
  • 11.1.1 Global Recurrent Glioblastoma Multiforme Treatment Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Recurrent Glioblastoma Multiforme Treatment Price and Trend Forecast (2019-2025)
• 11.2 Global Recurrent Glioblastoma Multiforme Treatment Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Recurrent Glioblastoma Multiforme Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Recurrent Glioblastoma Multiforme Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Recurrent Glioblastoma Multiforme Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Recurrent Glioblastoma Multiforme Treatment Production, Revenue Forecast (2019-2025)
• 11.3 Global Recurrent Glioblastoma Multiforme Treatment Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Recurrent Glioblastoma Multiforme Treatment Consumption Forecast (2019-2025)
  • 11.3.2 Europe Recurrent Glioblastoma Multiforme Treatment Consumption Forecast (2019-2025)
  • 11.3.3 China Recurrent Glioblastoma Multiforme Treatment Consumption Forecast (2019-2025)
  • 11.3.4 Japan Recurrent Glioblastoma Multiforme Treatment Consumption Forecast (2019-2025)
• 11.4 Global Recurrent Glioblastoma Multiforme Treatment Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Recurrent Glioblastoma Multiforme Treatment Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List